BMO Capital Maintains Outperform on Aptinyx, Lowers Price Target to $13

BMO Capital maintains Aptinyx (NASDAQ:APTX) with a Outperform and lowers the price target from $15 to $13.

Benzinga · 11/13/2019 14:08

BMO Capital maintains Aptinyx (NASDAQ:APTX) with a Outperform and lowers the price target from $15 to $13.